Advocating for the implementation of the new nomenclature for steatotic liver disease: A call to action for the national associations [0.03%]
呼吁实施脂肪肝病新命名法：国家协会行动起来
Francesco Paolo Russo,Sven M Francque,Debbie L Shawcross et al.
Francesco Paolo Russo et al.
Reply to: "A comment on `A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B'" [0.03%]
“慢性HBeAg阴性乙型肝炎患者停用核苷(酸)类似物药物的多中心随机对照试验”的评论及回复
Florian van Bömmel,Thomas Berg
Florian van Bömmel
Uric acid may serve as the sixth cardiometabolic criterion for defining MASLD [0.03%]
尿酸可能是定义MASLD的第六个心血管代谢标准
Linfeng He,Kangli Qiu,Wenbin Zheng et al.
Linfeng He et al.
SARS-CoV-2 anti-spike IgG antibodies are present in all liver transplant recipients after fifth vaccine dose [0.03%]
第五剂疫苗接种后肝移植受者的抗刺突IgG抗体阳性率达100%
Jenny J H Smeets,Hannah van Malenstein,Schalk van der Merwe et al.
Jenny J H Smeets et al.
Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic gastrointestinal cancer under chemotherapy between NAFLD and MASLD [0.03%]
从NAFLD到MASLD：不可切除的消化道肿瘤患者化疗预后在NAFLD和MASLD中相似
Hiroyuki Suzuki,Toshimitsu Tanaka,Shotaro Yamaguchi et al.
Hiroyuki Suzuki et al.
Reply to: "Comparing hypothermic oxygenated and normothermic liver machine perfusion: Translation matters" [0.03%]
对“比较低温氧合和常温肝脏机械灌注：转化问题”的回复
Alessandro Parente,Chunbao Jiao,Janina Eden et al.
Alessandro Parente et al.
Jimmy Che-To Lai,Grace Lai-Hung Wong,Vincent Wai-Sun Wong et al.
Jimmy Che-To Lai et al.
Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD score [0.03%]
提高肝移植后肝细胞癌复发的预测：从DCP加AFP-L3模型到GALAD评分
Magdalena Hahn,Adam Herber,Thomas Berg et al.
Magdalena Hahn et al.
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis [0.03%]
一种新的临床和预后表征肝硬化失代偿模式的方法
Marta Tonon,Roberta D&#x;Ambrosio,Valeria Calvino et al.
Marta Tonon et al.
Background & aims: The prognostic impact of acute decompensation (AD), i.e. the development of complications that require hospitalization, has recently been assessed. However, complications of cirrhosis do not necessarily...
Multicenter Study
Journal of hepatology. 2024 Apr;80(4):603-609. DOI:10.1016/j.jhep.2023.12.005 2024
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma [0.03%]
肝细胞癌的组织活检与液体活检：作用及意义
Brandon M Lehrich,Josephine Zhang,Satdarshan P Monga et al.
Brandon M Lehrich et al.
The diagnosis and management of hepatocellular carcinoma (HCC) have improved significantly in recent years. With the introduction of immunotherapy-based combination therapy, there has been a notable expansion in treatment options for patien...